// App-Quantinova.ai

: Treatment Resistant Primary Membranous Nephropathy due to concomitant occurrence of Secondary Membranous Nephropathy from Merkle Cell Carcinoma.

Researchers

Presenter

  • Tariku T. Gudura

Principal Investigators

  • Leal Herlitz

  • Hernan Rincon-Choles

Medical Centers

  • Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH

  • Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Membranous glomerulonephritis

  • Chronic kidney disease

  • Subdural hematoma

  • Renal disease

  • Cardiac arrest

  • Hypertension

  • Albuminuria

  • Venous thrombosis

  • Solid malignancies

  • Dementia

  • Hematoma

  • Seizures sensorineural deafness ataxia mental retardation electrolyte imbalance

Biomarkers

  • Creatinine

  • Human albumin

Drug/Treatment

  • Lisinopril

  • Cipril

  • Prednisone

  • Tacrolimus

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved